TABLE 1.
Latency to onset and time spent (mean ± standard error) in the different sleep-wakefulness states observed in the first 2 h after unilateral carbachol miroinjections in the rostrodorsal pontine tegmentum at the level of the PLCα (n = 7 cats).
Carbachol dose (M) | State | Latency (min) |
Time spent (min) |
|
Hour 1 | Hour 2 | |||
0.1 | Wa | 1.6 ± 0.6 | 31.0 ± 8.8 | 20.3 ± 10.8 |
SPGO | 15.8 ± 9.1 | 20.3 ± 8.6 | 14.5 ± 7.7 | |
Wt | 40.8 ± 22.7 | 8.8 ± 4.7 | 23 ± 11.2 | |
REM | >90 | 0 | 2.3 ± 2.3 | |
0.01 | Wa | 24.8 ± 11.6 | 6.2 ± 1.8 | 15.5 ± 11 |
SPGO | 3.9 ± 1.76 | 45.2 ± 3.8 | 37.8 ± 9.1 | |
Wt | 40.8 ± 12.6 | 8.6 ± 4.2 | 4 ± 2.1 | |
REM | >110 | 0 | 2.8 ± 2.8 |
SPGO, EEG synchronization with pontogeniculooccipital activity; REM, REM sleep; Wa, wakefulness with muscle atonia; Wt, wakefulness with muscle tone.